Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks.

Aberg, Judith A

Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks. [electronic resource] - AIDS research and human retroviruses Oct 2012 - 1184-95 p. digital

Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1931-8405

10.1089/aid.2011.0327 doi


Acquired Immunodeficiency Syndrome--drug therapy
Adult
Aged
Atazanavir Sulfate
Biomarkers--blood
CD4 Lymphocyte Count
Darunavir
Disease Progression
Drug Administration Schedule
Drug Resistance, Viral
Drug Therapy, Combination
Female
Glomerular Filtration Rate
HIV Protease Inhibitors--administration & dosage
HIV-1--drug effects
Humans
Insulin Resistance
Lipids--blood
Male
Middle Aged
Oligopeptides--administration & dosage
Pilot Projects
Pyridines--administration & dosage
RNA, Viral--blood
Ritonavir--administration & dosage
Sulfonamides--administration & dosage
Time Factors
Treatment Outcome
Viral Load
Young Adult